Roundup: U.S. FDA authorizes Pfizer COVID-19 booster for children ages 5 to 11

LOS ANGELES, May 17 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Tuesday granted emergency use authorization (EUA) for a booster dose of the Pfizer-BioNTech COVID-19 vaccine for children 5 through 11 years of age at least five months after completion of the primary vaccine series.

On Jan. 3, the FDA authorized the use of a single booster dose of the Pfizer-BioNTech COVID-19 vaccine for individuals 12 through 15 years of age after completion of primary vaccination.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 48
Cxense type: NA
User access status: 3
Join our Telegram channel to get our Evening Alerts and breaking news highlights

Next In World

Dutch uni gets cyber ransom money back – with interest
Philippines President Marcos vetoes economic zone bill championed by sister
Striking Paris airport workers call new walkout on July 8-10
At least five killed in magnitude 6.1 quake on Iran Gulf coast
Protests break out in Uzbek autonomous region over constitution reform plan
Google to delete user data on trips to abortion clinics
Iranian-flagged tanker in Greece tugged to Piraeus port
Indian police arrest 'masterminds' behind murder of Hindu tailor, officials say
Australians rally against U.S. overturning of key abortion ruling
Hamburg senator warns of hot water rationing if gas shortage becomes acute

Others Also Read